Army veteran pushes Temple Massager into 911 centers nationwide

Army veteran and inventor Joe Meisch is expanding his drug-free Temple Massager with a goal of placing one in every U.S. 911 dispatch center. A new four-week clinical study showing fewer headache days and improved anxiety scores gives the veteran-owned company fresh momentum as it seeks growth, government contracts and broader first-responder adoption.

Why it matters: - Meisch Temple Massager, Inc. is trying to turn a veteran-built wellness tool into a standard option for high-stress workplaces, starting with 911 dispatch centers. - The company’s new study gives the product its strongest clinical support yet, which could help with sales, contracting and wider adoption. - Meisch also plans to keep tying growth to donations for first responders, extending the product’s mission beyond commercial expansion.

What happened: - Army veteran and inventor Joe Meisch is taking the patented Temple Massager nationwide. - Meisch’s goal is to place one Temple Massager in every 911 dispatch center in the United States. - The Temple Massager is a handheld, non-electric, drug-free tool designed for self-massage around the temples and facial muscles. - Meisch says he created the device after dealing with headaches, jaw clenching and tension near the end of his Army career. - A new four-week observational study found fewer headache days and improved anxiety measures among participants, with no adverse events reported.

The details: - The study was conducted under independent Institutional Review Board oversight and registered with ClinicalTrials.gov. - The study included 35 women. - Thirty participants showed improvement on a commonly used anxiety-symptom measure over four weeks. - Participants reported about one-third fewer headache days per week during the study period. - Researchers recorded no adverse events across 286 safety assessments. - Meisch Temple Massager, Inc. is a certified Service-Disabled Veteran-Owned Small Business based in Cazadero, California. - The company says the product is made in the United States. - Meisch has donated more than 6,000 Temple Massagers over more than 15 years to deployed service members, veterans and first responders. - The California Army National Guard’s 235th Engineer Company used the device during pre-mobilization training and deployment in Afghanistan. - Temple Massagers were also donated to wounded warriors and their families at the National Naval Medical Center. - In 2023, 75 Temple Massagers were donated to the Santa Rosa Police Department. - Within 24 hours, a 911 dispatcher with a severe migraine used the tool for about 10 minutes and reported enough relief to stay on shift. - Denver 911 later bought Temple Massager kits after staff reported positive experiences.

Between the lines: - The clinical data gives Meisch a stronger case for selling into public-safety and government channels, where evidence and procurement readiness matter. - The dispatch-center push fits the product’s existing use pattern: short, on-shift relief for people working under sustained stress. - Meisch is framing the business as both a mission and a memorial to two men he served with, Curtis and Mike, who died during and after his Army years. - Lynn Lowder, founder and CEO of Veteran Business Project, said the research could open new doors for the business and highlighted Meisch’s focus on using growth to serve others.

What’s next: - Meisch Temple Massager, Inc. plans to expand production and distribution. - The company also aims to pursue government contracting opportunities and international partnerships. - Meisch says a portion of product sales will continue supporting donations to first responders. - The company’s long-term target remains placing a Temple Massager in every 911 dispatch center in the U.S. - More information is available at TempleMassager.com and VeteranBusinessProject.org.

The bottom line: - A small veteran-owned company is using new clinical data to try to move a niche wellness tool into public-safety systems nationwide, with first responders at the center of its growth plan.